Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

As artificial intelligence (AI) continues to develop at a rapid pace, even the most sophisticated general counsel (GC) and in-house legal teams ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Chemistry labs are also making effective use of AI. Repetitive and time-consuming laboratory tasks are now being performed by ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

In the first few days of his second presidential term, newly inaugurated President Trump signed a number of executive orders that will have an ...

Despite major advances in artificial intelligence (AI) research for healthcare, the deployment and adoption of AI technologies remain limited in clinical practice. This paper describes the FUTURE-AI ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.